ImmunoPrecise Antibodies Ltd. - Common Shares, no par value (IPA)

Historical Holders from Q4 2020 to Q3 2025

Symbol
IPA
Type / Class
Equity / Common Shares, no par value
Shares outstanding
31,523,534
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
10,000
Holdings value
$17,500
% of all portfolios
0%
Number of holders
1
Number of sells
-24
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ImmunoPrecise Antibodies Ltd. - Common Shares, no par value (IPA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Charmquark TWEE 5.8% $731,346 1,828,365 Charmquark TWEE 31 Dec 2024

Institutional Holders of ImmunoPrecise Antibodies Ltd. - Common Shares, no par value (IPA)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 10,000 $17,500 -$4,225,789 $1.75 1
2025 Q2 4,000,486 $4,229,364 +$106,912 $1.06 24
2025 Q1 3,931,347 $1,479,735 +$760,417 $0.3765 23
2024 Q4 1,906,989 $785,803 +$4,522 $0.4117 18
2024 Q3 1,897,106 $1,212,138 +$145,339 $0.6390 17
2024 Q2 1,656,275 $1,677,049 -$67,183 $1.01 19
2024 Q1 1,671,573 $2,543,489 -$139,367 $1.52 23
2023 Q4 1,726,648 $2,952,234 +$600,554 $1.71 22
2023 Q3 1,180,449 $2,160,639 -$88,601 $1.83 16
2023 Q2 1,432,450 $4,292,408 -$520,632 $2.96 15
2023 Q1 1,605,284 $4,502,090 +$481,596 $2.77 15
2022 Q4 1,427,634 $7,443,222 -$36,565 $5.21 19
2022 Q3 1,417,106 $5,651,643 +$83,931 $3.99 16
2022 Q2 1,365,778 $5,263,327 -$47,650 $3.85 17
2022 Q1 1,312,831 $6,741,558 -$232,854 $5.14 14
2021 Q4 1,292,326 $6,949,376 +$205,270 $5.36 19
2021 Q3 1,258,613 $7,847,356 -$360,077 $6.22 23
2021 Q2 1,370,865 $8,265,023 -$7,038 $6.03 21
2021 Q1 1,361,542 $13,365,000 +$7,995,959 $9.82 17
2020 Q4 522,673 $7,830,000 +$7,829,989 $14.97 13